These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 25495260)

  • 1. Pharmacological approaches for Alzheimer's disease: neurotransmitter as drug targets.
    Prakash A; Kalra J; Mani V; Ramasamy K; Majeed AB
    Expert Rev Neurother; 2015 Jan; 15(1):53-71. PubMed ID: 25495260
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Amyloid clearance as a treatment target against Alzheimer's disease.
    Kurz A; Perneczky R
    J Alzheimers Dis; 2011; 24 Suppl 2():61-73. PubMed ID: 21422524
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Advances in the therapy of Alzheimer's disease: targeting amyloid beta and tau and perspectives for the future.
    Hampel H; Schneider LS; Giacobini E; Kivipelto M; Sindi S; Dubois B; Broich K; Nisticò R; Aisen PS; Lista S
    Expert Rev Neurother; 2015 Jan; 15(1):83-105. PubMed ID: 25537424
    [TBL] [Abstract][Full Text] [Related]  

  • 4. beta-Amyloid as a molecular therapeutic target in Alzheimer's disease.
    Adlard PA; James SA; Bush AI; Masters CL
    Drugs Today (Barc); 2009 Apr; 45(4):293-304. PubMed ID: 19499094
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacological treatment for Alzheimer's disease: current approaches and future strategies.
    Fan LY; Chiu MJ
    Acta Neurol Taiwan; 2010 Dec; 19(4):228-45. PubMed ID: 21213151
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting nascent soluble Aβ42 for potential Alzheimer drug development.
    Zhang M; Hausmann L; Song W
    J Neurochem; 2013 May; 125(3):329-31. PubMed ID: 23405973
    [No Abstract]   [Full Text] [Related]  

  • 7. Investigational drugs in Alzheimer's disease: current progress.
    Berk C; Paul G; Sabbagh M
    Expert Opin Investig Drugs; 2014 Jun; 23(6):837-46. PubMed ID: 24702504
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neurotransmitter deficits in behavioural and psychological symptoms of Alzheimer's disease.
    Lanari A; Amenta F; Silvestrelli G; Tomassoni D; Parnetti L
    Mech Ageing Dev; 2006 Feb; 127(2):158-65. PubMed ID: 16297434
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alzheimer's disease: clinical trials and drug development.
    Mangialasche F; Solomon A; Winblad B; Mecocci P; Kivipelto M
    Lancet Neurol; 2010 Jul; 9(7):702-16. PubMed ID: 20610346
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel insights for the treatment of Alzheimer's disease.
    Kurz A; Perneczky R
    Prog Neuropsychopharmacol Biol Psychiatry; 2011 Mar; 35(2):373-9. PubMed ID: 20655969
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Strategies, development, and pitfalls of therapeutic options for Alzheimer's disease.
    Haas C
    J Alzheimers Dis; 2012; 28(2):241-81. PubMed ID: 21987594
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drug development in dementia.
    Cunningham EL; Passmore AP
    Maturitas; 2013 Nov; 76(3):260-6. PubMed ID: 23707728
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel disease-modifying therapies for Alzheimer's disease.
    Jiang T; Yu JT; Tan L
    J Alzheimers Dis; 2012; 31(3):475-92. PubMed ID: 22669013
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Medical treatment of Alzheimer's disease].
    López-Pousa S; Serra-Mestres J
    Rev Neurol; 1998 Jun; 26(154):1054-60. PubMed ID: 9658492
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The translocator protein as a drug target in Alzheimer's disease.
    Chua SW; Kassiou M; Ittner LM
    Expert Rev Neurother; 2014 Apr; 14(4):439-48. PubMed ID: 24625007
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rethinking Alzheimer's disease therapy: are mitochondria the key?
    Ankarcrona M; Mangialasche F; Winblad B
    J Alzheimers Dis; 2010; 20 Suppl 2():S579-90. PubMed ID: 20463405
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alzheimer's disease 2012: the great amyloid gamble.
    Marchesi VT
    Am J Pathol; 2012 May; 180(5):1762-7. PubMed ID: 22472273
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Concepts for the treatment of Alzheimer's disease: molecular mechanisms and clinical application.
    Pietrzik C; Behl C
    Int J Exp Pathol; 2005 Jun; 86(3):173-85. PubMed ID: 15910551
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Neurotransmitters in Alzheimer's disease].
    Manzano-Palomo S; De la Morena-Vicente MA; Barquero MS
    Rev Neurol; 2006 Mar 16-31; 42(6):350-3. PubMed ID: 16575771
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Current and emerging therapies for Alzheimer's disease.
    Nygaard HB
    Clin Ther; 2013 Oct; 35(10):1480-9. PubMed ID: 24139420
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.